NextPlat Corp

Aktienanalyse zu NextPlat Corp (NXPL)

$9.260

-0.059 (-0.64%)Zum Schluss

Loading chart…
High
9.850
Open
9.400
VWAP
9.40
Vol
117.06K
Mkt Cap
21.40M
Low
9.100
Amount
1.10M
EV/EBITDA, TTM
-21.26

NextPlat Corp is a consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. It is operating in the e-Commerce and Healthcare sectors. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally. The Company operates an e-Commerce communications division offering voice, data, tracking, and Internet of Things (IoT) products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. Additionally, the Company provides a comprehensive array of Satellite Industry communication services and related equipment sales. It also utilizes an artificial-intelligence (AI)-powered digital advertising platform service enabling it to reach consumers across social media channels.

AI analysis of NextPlat Corp (NXPL)

buy

NextPlat Corp (NXPL) is a good buy right now due to its recent acquisition of a pharmacy that generated $5.6 million in sales for 2025, indicating strong market potential. Additionally, the stock has shown a significant year-to-date change of +61.04% and an RSI of 80.714, suggesting strong momentum. However, a risk to consider is the negative net income reported for Q1 2026, which was -$1.118 million, highlighting ongoing financial challenges.

Bewertungskennzahlen

The current forward P/E ratio for NextPlat Corp (NXPL) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
-0.19
Current EV/EBITDA
-21.26
Überbewertet
1.55
Unterbewertet
-1.93

Forward P/S

Strongly Overvalued
5Y Average P/S
0.01
Current P/S
0.35
Überbewertet
0.06
Unterbewertet
-0.04

Alphio AI Price Scenarios for NXPL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NXPL

$1.03

Szenariopreis

B

Base

Base · 50%NXPL

$0.96

Szenariopreis

B

Bear

Bear · 25%NXPL

$0.89

Szenariopreis

Event-Zeitleiste

2026-07-20 (ET)

08:30:00

NextPlat's PharmcoRx Subsidiary Accredited by Pharmacy Boards

2026-07-15 (ET)

08:31:00

NextPlat Acquires Independent Pharmacy in Florida for $1.5M

2026-05-19 (ET)

09:40:00

NextPlat Corp Trading Halted Due to Volatility

2026-05-06 (ET)

16:40:00

NextPlat Files to Sell 2.65M Shares of Common Stock

2026-04-29 (ET)

08:00:00

NextPlat Expects Q1 2026 Healthcare Operations Revenue to Decline to $6.7M-$9.6M

News

NXPL FAQ — answered by Alphio AI

NextPlat Corp is a consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. It is operating in the e-Commerce and Healthcare sectors. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally. The Company operates an e-Commerce communications division offering voice, data, tracking, and Internet of Things (IoT) products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. Additionally, the Company provides a comprehensive array of Satellite Industry communication services and related equipment sales. It also utilizes an artificial-intelligence (AI)-powered digital advertising platform service enabling it to reach consumers across social media channels. It operates in the Technology sector (TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE) industry).

NextPlat Corp (NXPL) is a good buy right now due to its recent acquisition of a pharmacy that generated $5.6 million in sales for 2025, indicating strong market potential. Additionally, the stock has shown a significant year-to-date change of +61.04% and an RSI of 80.714, suggesting strong momentum. However, a risk to consider is the negative net income reported for Q1 2026, which was -$1.118 million, highlighting ongoing financial challenges.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten